title: [Caspases participarion in the cell death induced by GD2-specific monoclonal antibody].
abstract: The participation of the main caspases in the cytotoxic effects induced by monoclonal antibody 14G2a specific against tumor-associated ganglioside GD2 was studied in the EL-4 cells. It has been found constitutive expression ofprocaspases genes in the EL-4 cells; incubation of the cells with 14G2a antibodies didnot result in increasing of the procaspases expression. Weak enzymatic activity of caspases has been shown using fluorescent labeled substrates. At the same cell death level, activity of caspase-3 and caspase-9 in the cells incubated with 14G2a was about 7.5- and 3-fold lower than in cells after incubation with staurosporine. Pan caspase inhibitor Z-VAD-FMK, and caspase-3 inhibitor reduced the cytotoxic effects induced by 14G2a at 9-16 and 6-13%, respectively. At the same conditions, pan caspase inhibitor decreased staurosporine-induced apoptosis at 55-65%. Inhibitors of other caspases had no effect on the cell death triggered by the antibodies. Inhibition analysis demonstrated also that caspases did not involved in the cell volume decreasing and permeabilization of the cell plasma membrane, which were the first stages of anti-GD2-mAb-induced cell death in the EL-4 cells. Thus, despite the slight activation of caspases during the cell death induced by antibodies directed to GD2, they do not play a key role and do not determine the mechanism of cell death triggered through the tumor-associated ganglioside GD2.
authors.forename: P A
authors.initials: PA
authors.lastname: Vishniakova
authors.forename: I I
authors.initials: II
authors.lastname: Doronin
authors.forename: I V
authors.initials: IV
authors.lastname: Holodenko
authors.forename: D Iu
authors.initials: DIu
authors.lastname: Riazantsev
authors.forename: I M
authors.initials: IM
authors.lastname: Molotkovskaia
authors.forename: R V
authors.initials: RV
authors.lastname: Holodenko
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D017209:Apoptosis / Q000187:drug effects*; D053148:Caspase 3 / Q000096:biosynthesis* / Q000235:genetics; D053453:Caspase 9 / Q000096:biosynthesis* / Q000235:genetics; D061945:Caspase Inhibitors / Q000008:administration & dosage; D045744:Cell Line, Tumor; D005732:Gangliosides / Q000096:biosynthesis; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D009447:Neuroblastoma / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D019311:Staurosporine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D061945:Caspase Inhibitors; D005732:Gangliosides; C019403:ganglioside, GD2; D053148:Caspase 3; D053453:Caspase 9; D019311:Staurosporine